The Precision Medicine Initiative
The president recently announced the Precision Medicine Initiative which would be a $215 million investment from the 2016 budget (see here for more details: http://www.nih.gov/precisionmedicine/.
The $215 million investment from the 2016 budget would be broken down as follows:
- $130 million to NIH for development of a million person US cohort
- $70 million to the NCI to identify drivers of cancer and develop more effective therapies using this knowledge
- $10 million to the FDA to help develop robust databases and the regulatory components for these
- $5 million to the Office of the National Coordinator for Heath Information Technology (ONC) to develop the standards and requirements for privacy and enable secure exchange of information across data systems.
The overarching objectives of this initiative are:
- More and better treatments for cancer
- Creation of a voluntary national research cohort
- Commitment to protecting privacy
- Regulatory modernization
- Public-private partnerships
The expectation is that a RFA or series of RFAs will be coming out before the end of 2015 and Case Comprehensive Cancer Center should be well positioned to apply given our strengths across many cancers. When the RFA or RFAs are released additional communication will be sent in order to gather responses for participation.